The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice
Open accessAbstract
PTEN (phosphatase and tensin homolog deleted on chromosome ten) is a lipid phosphatase that counteracts the function of phosphatidylinositol-3 kinase (PI3K). Loss of function of PTEN results in constitutive activation of AKT and downstream effectors and correlates with many human cancers, as well as various brain disorders, including macrocephaly, seizures, Lhermitte–Duclos disease, and autism. We previously generated a conditional Pten knock-out mouse line with Pten loss in limited postmitotic neurons in the cortex and hippocampus.Pten-null neurons developed neuronal hypertrophy and loss of neuronal polarity. The mutant mice exhibited macrocephaly and behavioral abnormalities reminiscent of certain features of human autism. Here, we report that rapamycin, a specific inhibitor of mammalian target of rapamycin complex 1 (mTORC1), can prevent and reverse neuronal hypertrophy, resulting in the amelioration of a subset of PTEN-associated abnormal behaviors, providing evidence that the mTORC1 pathway downstream of PTEN is critical for this complex phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally in animal models of autism spectrum disorder (ASD), altered mTORC1 signaling contributes to the observed synaptic dysfunction and aberrant network connectivity (13,15,(21)(22)(23)(24)(25)(26)(27).”
From Analysis of proteins that rapidly change upon mechanistic/mammalian target of rapamycin complex 1 (mTORC1) repression identifies parkinson protein 7 (PARK7) as a novel protein aberrantly expressed in tuberous sclerosis complex (TSC) (2016) · cites this paper as [21]
Experimental — accuracy not yet measuredIn the citing paper
“Notably, pharmacological and genetic manipulations have successfully rescued both structural and behavioral phenotypes in PTEN86, FMR1 (ref. 87) and MECP2 (ref. 88) knockout mice.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [86]
In the citing paper
“That behavioral recovery in each of these rescue strategies was paralleled by reversal of spine pathologies underscores the importance of these structural perturbations in the pathogenesis of ASDs and comorbid disorders and the potential for the use of animal models in the development of therapeutics.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [86]
In the citing paper
“Rapamycin successfully reduced cognitive impairment and social behavior deficit in mouse models of tuberous sclerosis 61-63 and improved behavior in adult mice with a deletion of PTEN 64 .”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [64]
In the citing paper
“Experimental interventions, working through diverse genetic and pharmacological mechanisms, rescue subsets of behavioral abnormalities in these mouse models (31, 43, 48–52).”
From Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism (2012) · cites this paper as [52]
In the citing paper
“Target strategies draw from therapeutics under investigation for other neurodevelopmental disorders and hypotheses emerging from mutations in synaptic genes identified in small numbers of individuals with autism spectrum disorders (43, 49, 52).”
From Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism (2012) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 5,237
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Self-citationTSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,010
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Pten Regulates Neuronal Arborization and Social Interaction in Mice
Kwon, C.-H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., Li, Y., Baker, S. J., & Parada, L. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.023 · Cited by 970
Self-citationAkt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882
Cited by
Sorted by citations
Items 201–300 of 441
Hoeffer, C. A., Santini, E., Ma, T., Arnold, E. C., Whelan, A., Wong, H., Pierre, P., Pelletier, J., & Klann, E. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00342.2012 · Cited by 37
Gene expression analysis in lymphoblasts derived from patients with autism spectrum disorder
Yasuda, Y., Hashimoto, R., Yamamori, H., Ohi, K., Fukumoto, M., Umeda‐Yano, S., Mohri, I., Itô, A., Taniike, M., & Takeda, M. (2011) · Molecular Autism · doi:10.1186/2040-2392-2-9 · Cited by 39
The Ubiquitin System: a Regulatory Hub for Intellectual Disability and Autism Spectrum Disorder
Kasherman, M. A., Premarathne, S., Burne, T. H. J., Wood, S. A., & Piper, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01881-x · Cited by 41
Srivastava, S., Jo, B., Zhang, B., Frazier, T. W., Gallagher, A. S., Peck, F. C., Levin, A. R., Mondal, S., Li, Z., Filip‐Dhima, R., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac111 · Cited by 37
Fretham, S. J. B., Carlson, E. S., & Georgieff, M. (2013) · Journal of Nutrition · doi:10.3945/jn.112.168617 · Cited by 36
NS ‐Pten knockout mice show sex‐ and age‐specific differences in ultrasonic vocalizations
Binder, M. S., & Lugo, J. N. (2017) · Brain and Behavior · doi:10.1002/brb3.857 · Cited by 36
The promising trajectory of autism therapeutics discovery
Silverman, J. L., & Crawley, J. N. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.007 · Cited by 35
Huang, X., McMahon, J. J., Yang, J., Shin, D., & Huang, Y. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.003 · Cited by 35
Beining, M., Mongiat, L. A., Schwarzacher, S. W., Cuntz, H., & Jedlička, P. (2017) · eLife · doi:10.7554/elife.26517 · Cited by 36
In Vivo AAV1 Transduction With hRheb(S16H) Protects Hippocampal Neurons by BDNF Production
Jeon, M., Nam, J. H., Shin, W.-H., Leem, E., Jeong, K. H., Jung, U. J., Bae, Y., Jin, Y., Kholodilov, N. G., Burke, R. E., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.241 · Cited by 34
Dietary interventions that reduce mTOR activity rescue autistic-like behavioral deficits in mice
Wu, J., de Theije, C. G. M., da Silva, S. L., Abbring, S., van der Horst, H. J., Broersen, L. M., Willemsen, L. E. M., Kas, M. J., Garssen, J., & Kraneveld, A. D. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.016 · Cited by 35
Zeng, L., McDaniel, S. S., Rensing, N. R., & Wong, M. (2010) · Cell Cycle · doi:10.4161/cc.9.12.11866 · Cited by 34
Annual Research Review: Transgenic mouse models of childhood‐onset psychiatric disorders
Robertson, H. R., & Feng, G. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02380.x · Cited by 33
Neurobiological Mechanisms of Autism Spectrum Disorder and Epilepsy, Insights from Animal Models
Sierra-Arregui, T., Llorente, J., Mínguez, P., Tønnesen, J., & Peñagarikano, O. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.043 · Cited by 34
mTOR and epileptogenesis in developmental brain malformations
Wong, M., & Crino, P. B. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02858.x · Cited by 32
Linking Autism Risk Genes to Disruption of Cortical Development
García-Forn, M., Boitnott, A., Akpinar, Z., & Rubeis, S. D. (2020) · Cells · doi:10.3390/cells9112500 · Cited by 35
RAB39B Deficiency Impairs Learning and Memory Partially Through Compromising Autophagy
Niu, M., Zheng, N., Wang, Z., Gao, Y., Luo, X., Chen, Z., Fu, X., Wang, Y., Wang, T., Liu, M., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.598622 · Cited by 33
Kinase Signaling in Dendritic Development and Disease
Nourbakhsh, K., & Yadav, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.624648 · Cited by 31
Zapata‐Muñoz, J., Villarejo‐Zori, B., Largo‐Barrientos, P., & Boya, P. (2021) · Cell Stress · doi:10.15698/cst2021.07.253 · Cited by 33
Séjourné, J., Llaneza, D. C., Kuti, O. J., & Page, D. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136494 · Cited by 31
Dysregulated mTORC1-Dependent Translational Control: From Brain Disorders to Psychoactive Drugs
Santini, E., & Klann, E. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00076 · Cited by 34
Acosta, M. T., Bearden, C. E., Castellanos, F. X., Cutting, L. E., Elgersma, Y., Gioia, G. A., Gutmann, D. H., Lee, Y., Legius, E., Muenke, M., et al. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35535 · Cited by 31
Self-citationNaringin: A Protector of the Nigrostriatal Dopaminergic Projection
Jung, U. J., Leem, E., & Kim, S. R. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.2.124 · Cited by 34
Experimental Models to Study Autism Spectrum Disorders: hiPSCs, Rodents and Zebrafish
Pensado‐López, A., Veiga-Rúa, S., Carracedo, Á., Allegue, C., & Sanchez, L. E. (2020) · Genes · doi:10.3390/genes11111376 · Cited by 34
The utility of rodent models of autism spectrum disorders
Lázaro, M. T., & Golshani, P. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000183 · Cited by 36
Tang, H., Long, H., Zeng, C., Li, Y., Bi, F., Wang, J., Qian, H., & Xiao, B. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.143 · Cited by 28
Levels of Leydig cell autophagy regulate the fertility of male naked mole-rats
Yang, W., Li, L., Huang, X., Kan, G., Lin, L., Cheng, J., Chen, X., Sun, W., Cong, W., Zhao, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22088 · Cited by 29
4E-BP2–dependent translation in parvalbumin neurons controls epileptic seizure threshold
Sharma, V. K., Sood, R., Lou, D., Hung, T.-Y., Lévesque, M., Han, Y., Levett, J. Y., Wang, P., Murthy, S., Tansley, S. N., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025522118 · Cited by 29
Reciprocal control of translation and transcription in autism spectrum disorder
Longo, F., & Klann, E. (2021) · EMBO Reports · doi:10.15252/embr.202052110 · Cited by 29
Neurofibromin Modulates Adult Hippocampal Neurogenesis and Behavioral Effects of Antidepressants
Li, Y., Li, Y., McKay, R. M., Riethmacher, D., & Parada, L. F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3469-11.2012 · Cited by 28
Self-citationModeling Social Communication Deficits in Mouse Models of Autism
Michetti, C. (2012) · Autism - Open Access · doi:10.4172/2165-7890.s1-007 · Cited by 30
Cullen, E. R., Tariq, K., Shore, A. N., Luikart, B. W., & Weston, M. C. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1354-22.2022 · Cited by 26
Defective phosphoinositide metabolism in autism
Groß, C. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23797 · Cited by 28
Cabral‐Costa, J. V., Andreotti, D. Z., de Mello, N. P., Scavone, C., Camandola, S., & Kawamoto, E. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-26814-6 · Cited by 27
mTOR plays an important role in cow's milk allergy-associated behavioral and immunological deficits
Wu, J., de Theije, C. G. M., da Silva, S. L., van der Horst, H. J., Reinders, M. T. M., Broersen, L. M., Willemsen, L. E. M., Kas, M. J., Garssen, J., & Kraneveld, A. D. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.035 · Cited by 28
Epilepsy and malformations of cortical development.
(2003) · PubMed · Cited by 27
Dhaliwal, N. K., Weng, O. Y., Dong, X., Bhattacharya, A., Ahmed, M. E., Nishimura, H., Choi, W. W. Y., Aggarwal, A., Luikart, B. W., Shu, Q., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114173 · Cited by 27
Rapamycin for Treatment of Epilepsy: Antiseizure, Antiepileptogenic, Both, or Neither?
Wong, M. (2011) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-11.2.66 · Cited by 27
White, A. R., Tiwari, D., MacLeod, M. C., Danzer, S. C., & Groß, C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105026 · Cited by 26
Current Review in Basic Science: Animal Models of Focal Cortical Dysplasia and Epilepsy
Nguyen, L. H., & Bordey, A. (2022) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597221098230 · Cited by 21
Targeted suppression of mTORC2 reduces seizures across models of epilepsy
Okoh, J. T., Mays, J., Bacq, A., Osés-Prieto, J. A., Tyanova, S., Chen, C.-J., Imanbeyev, K., Doladilhe, M., Zhou, H., Jafar‐Nejad, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42922-y · Cited by 26
Overview of genetic models of autism spectrum disorders
Patel, J., Lukkes, J. L., & Shekhar, A. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.10.002 · Cited by 29
Johnson, J. T., Fila, W. A., & Anumudu, C. K. (2025) · Applied Sciences · doi:10.3390/app151810285 · Cited by 29
Šimić, G., Vukić, V., Kopić, J., Krsnik, Ž., & Hof, P. R. (2020) · Biomolecules · doi:10.3390/biom11010002 · Cited by 26
Genetically encoded biosensor for fluorescence lifetime imaging of PTEN dynamics in the intact brain
Kagan, T., Gabay, M., Meenakshisundaram, A., Levi, Y., Eid, S., Malchenko, N., Maman, M., Nitzan, A., Ravotto, L., Zaidel‐Bar, R., et al. (2025) · Nature Methods · doi:10.1038/s41592-025-02610-9 · Cited by 25
Genomic Divergence in Swedish Warmblood Horses Selected for Equestrian Disciplines
Ablondi, M., Eriksson, S., Tetu, S., Sabbioni, A., Viklund, Å., & Mikko, S. (2019) · Genes · doi:10.3390/genes10120976 · Cited by 34
Sarn, N., Thacker, S., Lee, H., & Eng, C. (2021) · Molecular Autism · doi:10.1186/s13229-021-00448-4 · Cited by 25
MiR-4465 directly targets PTEN to inhibit AKT/mTOR pathway–mediated autophagy
Tao, Z., Feng, C., Mao, C., Ren, J., Tai, Y., Guo, H., Pu, M., Zhou, Y., Wang, G., & Wang, M. (2018) · Cell Stress and Chaperones · doi:10.1007/s12192-018-0946-6 · Cited by 24
Mammalian Target of Rapamycin at the Crossroad Between Alzheimer’s Disease and Diabetes
Liang, H., Nie, J., Skike, C. E. V., Valentine, J. M., & Orr, M. E. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_10 · Cited by 24
mTOR and Epileptogenesis in Developmental Brain Malformations
Wong, M., & Crino, P. B. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0065 · Cited by 23
Brain patterning perturbations following PTEN loss
Veleva-Rotse, B. O., & Barnes, A. P. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00035 · Cited by 22
Suzuki, Â. M., Griesi‐Oliveira, K., Machado, C. D. O. F., Vadasz, E., Zachi, E. C., Passos‐Bueno, M. R., & Sertie, A. L. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.175 · Cited by 23
Role of the PTEN signaling pathway in autism spectrum disorder
Lv, J., Cheng, T., Qiu, Z., & Zhou, W. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1382-3 · Cited by 23
Chai, A., Chen, X.-F., Xu, X.-S., Zhang, N., Li, M., Li, J., Zhang, L., Zhang, D., Zhang, X., Mao, R., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.699315 · Cited by 24
PTEN Regulates Dendritic Arborization by Decreasing Microtubule Polymerization Rate
Getz, S. A., Tariq, K., Marchand, D. H., Dickson, C. R., VI, J. R. H., Skelton, P. D., Wang, W., Li, M., Barry, J. M., Hong, J., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1835-21.2022 · Cited by 23
Nikolaeva, I., Kazdoba, T. M., Crowell, B., & D’Arcangelo, G. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.026 · Cited by 22
Self-reinforcing effects of mTOR hyperactive neurons on dendritic growth
Arafa, S. R., LaSarge, C. L., Pun, R. Y. K., Khademi, S., & Danzer, S. C. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.09.019 · Cited by 22
Sato, A., & Ikeda, K. (2021) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.08.005 · Cited by 22
Kurata, H., Shirai, K., Saito, Y., Okazaki, T., Ohno, K., Oguri, M., Adachi, K., Nanba, E., & Maegaki, Y. (2017) · Brain and Development · doi:10.1016/j.braindev.2017.07.005 · Cited by 21
Neonatal and Infantile Epilepsy: Acquired and Genetic ModelsPreprint
Galanopoulou, A. S., & Moshé, S. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022707 · Cited by 22
Tibarewal, P., Rathbone, V., Constantinou, G., Pearce, W. P., Adil, M., Varyova, Z., Folkes, L. K., Hampson, A., Classen, G. A. E., Alves, A., et al. (2022) · The Journal of Pathology · doi:10.1002/path.6009 · Cited by 19
Another piece of the autism puzzle
State, M. W. (2010) · Nature Genetics · doi:10.1038/ng0610-478 · Cited by 18
Gender issues in antiepileptogenic treatments
Pitkänen, A., Huusko, N., Ndode‐Ekane, X. E., Kyyriäinen, J., Lipponen, A., Lipsanen, A., Sierra, A., & Bolkvadze, T. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.037 · Cited by 19
Kas, M. J., Modi, M. E., Saxe, M., & Smith, D. G. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3464-y · Cited by 19
Chae, C. W., Lee, H. J., Choi, G. E., Jung, Y. H., Kim, J. S., Lim, J. R., Kim, S. Y., Hwang, I. K., Seong, J. K., & Han, H. J. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15131 · Cited by 18
Decreased nuclear Pten in neural stem cells contributes to deficits in neuronal maturation
Kang, S. C., Jaini, R., Hitomi, M., Lee, H., Sarn, N., Thacker, S., & Eng, C. (2020) · Molecular Autism · doi:10.1186/s13229-020-00337-2 · Cited by 19
Dysregulation of translational control signaling in autism spectrum disorders
Hooshmandi, M., Wong, C., & Khoutorsky, A. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109746 · Cited by 17
Patil, V., Guzmán, M. A., Carter, A. N., Rathore, G., Yoshor, D., Curry, D. J., Wilfong, A. A., Agadi, S., Swann, J. W., Adesina, A. M., et al. (2015) · Neuropathology · doi:10.1111/neup.12242 · Cited by 19
Pathophysiology of Status Epilepticus Revisited
Alshehri, R. S., Alrawaili, M. S., Zawawi, B. M. H., Alzahrany, M., & Habib, A. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157502 · Cited by 21
PTEN Regulates Mitochondrial Biogenesis via the AKT/GSK-3β/PGC-1α Pathway in Autism
Feng, C., Chen, Y., Zhang, Y., Yan, Y., Yang, M., Gui, H., & Wang, M. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.04.010 · Cited by 19
Aledo‐Serrano, Á., Carbó, A. V., Fenger, C., Gröppel, G., Hartlieb, T., Pascual, I., Herráez, E., Cabal-Paz, B., García‐Morales, I., Toledano, R., et al. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01395-z · Cited by 18
Vasić, V., Jones, M. S. O., Haslinger, D., Knaus, L. S., Schmeißer, M. J., Novarino, G., & Chiocchetti, A. G. (2021) · Genes · doi:10.3390/genes12111746 · Cited by 17
Autism Spectrum Disorder Genes: Disease-Related Networks and Compensatory Strategies
Lim, H. K., Yoon, J. H., & Song, M. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.922840 · Cited by 18
Aria, F., Pandey, K. R., & Alberini, C. M. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.11.016 · Cited by 17
The role of PTEN signaling in synaptic function: Implications in autism spectrum disorder
Nagy, G. S., Kawamoto, E. M., & Bridi, J. C. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136015 · Cited by 18
Hardan, A. Y., Jo, B., Frazier, T. W., Klaas, P., Busch, R. M., Dies, K. A., Filip‐Dhima, R., Snow, A. V., Eng, C., Hanna, R., et al. (2021) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2021.100733 · Cited by 16
Cullen, E. R., Safari, M., Mittelstadt, I., & Weston, M. C. (2023) · eLife · doi:10.7554/elife.91323 · Cited by 16
Fard, Y. A., Sadeghi, E. N., Pajoohesh, Z., Gharehdaghi, Z., Khatibi, D. M., Khosravifar, S., Pishkari, Y., Nozari, S., Hijazi, A., Pakmehr, S., et al. (2024) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32986 · Cited by 16
Wallin, D. J., Zamora, T., Alexander, M. L., Ennis, K. M., Tran, P. V., & Georgieff, M. (2017) · Pediatric Research · doi:10.1038/pr.2017.88 · Cited by 16
D’Amore, A., Sundberg, M., Lin, R., Lubbers, E., Winden, K. D., Yu, L., Gawlińska, K., Gawliński, D., Lopez, S. G., Choe, Y., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02916-2 · Cited by 15
Kim, N.-S., Ringeling, F. R., Zhou, Y., Nguyen, H. N., Temme, S. J., Lin, Y.-T., Eacker, S., Dawson, V. L., Dawson, T. M., Xiao, B., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.023 · Cited by 15
Cambiaghi, M., Magri, L., & Cursi, M. (2015) · Seizure · doi:10.1016/j.seizure.2015.02.015 · Cited by 14
Binder, M. S., Jones, D. G., Hodges, S. L., & Lugo, J. N. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112189 · Cited by 19
Autism Spectrum Disorder: The Cerebellum, Genes, and Pathways
D’Mello, S. R. (2025) · Neurology International · doi:10.3390/neurolint17100173 · Cited by 15
Differential effects by sex with Kmt5b loss
Wickramasekara, R. N., Robertson, B., Hulen, J., Hallgren, J., & Stessman, H. A. F. (2021) · Autism Research · doi:10.1002/aur.2516 · Cited by 15
Hooshmandi, M., Truong, V. T., Fields, E., Thomas, R. E., Wong, C., Sharma, V. K., Gantois, I., Roque, P. S., Chalkiadaki, K., Wu, N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109036 · Cited by 14
Microglial Dysfunction in Autism Spectrum Disorder
Meng, J., Zhang, L., & Zhang, Y. (2024) · The Neuroscientist · doi:10.1177/10738584241252576 · Cited by 15
Cross Talk between Cellular Redox Status, Metabolism, and p53 in Neural Stem Cell Biology
Forsberg, K., & Giovanni, S. D. (2014) · The Neuroscientist · doi:10.1177/1073858413514634 · Cited by 14
Not all that glitters is gold: A guide to critical appraisal of animal drug trials in epilepsy
Galanopoulou, A. S., & Mowrey, W. B. (2016) · Epilepsia Open · doi:10.1002/epi4.12021 · Cited by 14
Ucha, M., Coria, S. M., Núñez, A. E., Santos‐Toscano, R., Roura‐Martínez, D., Fernández‐Ruíz, J., Higuera‐Matas, A., & Ambrosio, E. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119836206 · Cited by 14
Lin, R., Learman, L. N., Na, C. H., Renuse, S., Chen, K. T., Chen, P. Y., Lee, G.-H., Xiao, B., Resnick, S. M., Troncoso, J. C., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.10.012 · Cited by 16
Protein synthesis as a modifiable target for autism‐related dendritic spine pathophysiologies
Lu, M., & Hsueh, Y. (2021) · FEBS Journal · doi:10.1111/febs.15733 · Cited by 15
Clipperton‐Allen, A. E., & Page, D. T. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037010 · Cited by 14
Cardona, E., Brunet, V., Baranek, É., Milhade, L., Cassy, S., Bobe, J., Calandreau, L., Roy, J., & Colson, V. (2022) · Biology · doi:10.3390/biology11081093 · Cited by 13
Avendaño-Lopez, S. S., Rodríguez-Marín, A. J., Lara-Castillo, M., Agresott-Carrillo, J., Lara-Cortés, L. E., Sánchez-Almanzar, J. F., Villamil-Cruz, S., Rojas-Rodríguez, L. C., Ariza-Salamanca, D. F., Gaviria-Carrillo, M., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092131 · Cited by 13
Canitano, R. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.024 · Cited by 13
Induced pluripotent stem cells from patients with focal cortical dysplasia and refractory epilepsy
Marinowic, D. R., Majolo, F., Sebben, A. D., da Silva, V. D., Lopes, T. G., Paglioli, E., Palmini, A., Machado, D. C., & da Costa, J. C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6264 · Cited by 14
Matthiesen, M., Khlaifia, A., Steininger, C. F. D., Dadabhoy, M., Mumtaz, U., & Arruda-Carvalho, M. (2023) · Molecular Brain · doi:10.1186/s13041-023-01028-8 · Cited by 13
Analysis of Fmr1 Deletion in a Subpopulation of Post‐Mitotic Neurons in Mouse Cortex and Hippocampus
Amiri, A., Sanchez‐Ortiz, E., Cho, W., Birnbaum, S. G., Xu, J., McKay, R. M., & Parada, L. F. (2014) · Autism Research · doi:10.1002/aur.1342 · Cited by 14
Self-citationA blueprint for research on Shankopathies: A view from research on autism spectrum disorder
Carbonetto, S. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22150 · Cited by 13
Metadata
- Authors
- Zhou, J., Blundell, J., Ogawa, S., Kwon, C.-H., Zhang, W., Sinton, C., Powell, C. M., & Parada, L. F.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- The University of Texas at Dallas (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-02-11
- Volume
- 29
- Issue
- 6
- Pages
- 1773-1783
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC3904448
- OpenAlex
- W2017097994
- Cited by
- 441
- References
- 52
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 17 · 2023: 17 · 2022: 19 · 2021: 22 · 2020: 49 · 2019: 16 · 2018: 24 · 2017: 28 · 2016: 22 · 2015: 37 · 2014: 31 · 2013: 32 · 2012: 39
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Funders
- Autism Speaks (AS1270, AS2126)
- Simons Foundation
- National Institute of Mental Health (K08MH065975, R01MH081164)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD065290)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- PTEN, mTORC1, rapamycin, neuronal hypertrophy, neuronal polarity, macrocephaly, autism-like behavior, postmitotic neurons, PI3K/Akt signaling, Lhermitte-Duclos disease, seizures, hippocampus, cortex
- MeSH terms
- Animals, Autistic Disorder, Female, Male, Mice, Inbred C57BL, Neurons, Transcription Factors, Mice, Knockout, Sirolimus, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review